# Olumiant

NDC: 0002-4479
Generic name: baricitinib
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220510

FDA application: NDA207924

## Active ingredients

- BARICITINIB: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-4479"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-4479
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=866e9f35-9035-4581-a4b1-75a621ab55cf